A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.
Behavioural intervention
Cancer
Cancer survivorship
Chemotherapy-induced peripheral neuropathy
Exercise
Systematic review
Journal
Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
14
07
2020
accepted:
19
01
2021
pubmed:
13
3
2021
medline:
3
3
2023
entrez:
12
3
2021
Statut:
ppublish
Résumé
Chemotherapy-induced peripheral neuropathy (CIPN) can result in functional difficulties. Pharmacological interventions used to prevent CIPN either show low efficacy or lack evidence to support their use and to date, duloxetine remains the only recommended treatment for painful CIPN. Non-pharmacological interventions such as exercise and behavioural interventions for CIPN exist. The aims were to (1) identify and appraise evidence on existing behavioural and exercise interventions focussed on preventing or managing CIPN symptoms, (2) describe psychological mechanisms of action by which interventions influenced CIPN symptoms, (3) determine the underpinning conceptual models that describe how an intervention may create behaviour change, (4) identify treatment components of each intervention and contextual factors, (5) determine the nature and extent of patient and clinician involvement in developing existing interventions and (6) summarise the relative efficacy or effectiveness of interventions to lessen CIPN symptoms and to improve quality of life, balance and muscle strength. A systematic search of Ovid Medline, Cochrane Library, EMBASE, PsycINFO, Health Management Information Consortium, Global Health and CINAHL was performed to identify articles published between January 2000 to May 2020, followed by OpenGrey search and hand-searching of relevant journals. Studies that explored behavioural and/or exercise interventions designed to prevent or improve symptoms of CIPN in adults who had received or were receiving neurotoxic chemotherapy for any type of cancer, irrespective of when delivered within the cancer pathway were included. Nineteen randomised controlled trials and quasi-experimental studies which explored behavioural (n=6) and exercise (n=13) interventions were included. Four studies were rated as methodologically strong, ten were moderate and five were weak. Ten exercise and two behavioural interventions, including those that improved CIPN knowledge and self-management resources and facilitated symptom self-reporting, led to reduced CIPN symptoms during and/or after chemotherapy treatment. The extent of potential benefits from the interventions was difficult to judge, due to study limitations. Future interventions should incorporate a clear theoretical framework and involve patients and clinicians in the development process. Our findings show exercise interventions have beneficial effects on CIPN symptoms although higher quality research is warranted. Behavioural interventions that increase patient's CIPN knowledge, improve self-management capacity and enable timely access to symptom management led to reduced CIPN symptoms.
Sections du résumé
BACKGROUND
Chemotherapy-induced peripheral neuropathy (CIPN) can result in functional difficulties. Pharmacological interventions used to prevent CIPN either show low efficacy or lack evidence to support their use and to date, duloxetine remains the only recommended treatment for painful CIPN. Non-pharmacological interventions such as exercise and behavioural interventions for CIPN exist.
PURPOSE
The aims were to (1) identify and appraise evidence on existing behavioural and exercise interventions focussed on preventing or managing CIPN symptoms, (2) describe psychological mechanisms of action by which interventions influenced CIPN symptoms, (3) determine the underpinning conceptual models that describe how an intervention may create behaviour change, (4) identify treatment components of each intervention and contextual factors, (5) determine the nature and extent of patient and clinician involvement in developing existing interventions and (6) summarise the relative efficacy or effectiveness of interventions to lessen CIPN symptoms and to improve quality of life, balance and muscle strength.
METHODS
A systematic search of Ovid Medline, Cochrane Library, EMBASE, PsycINFO, Health Management Information Consortium, Global Health and CINAHL was performed to identify articles published between January 2000 to May 2020, followed by OpenGrey search and hand-searching of relevant journals. Studies that explored behavioural and/or exercise interventions designed to prevent or improve symptoms of CIPN in adults who had received or were receiving neurotoxic chemotherapy for any type of cancer, irrespective of when delivered within the cancer pathway were included.
RESULTS
Nineteen randomised controlled trials and quasi-experimental studies which explored behavioural (n=6) and exercise (n=13) interventions were included. Four studies were rated as methodologically strong, ten were moderate and five were weak. Ten exercise and two behavioural interventions, including those that improved CIPN knowledge and self-management resources and facilitated symptom self-reporting, led to reduced CIPN symptoms during and/or after chemotherapy treatment.
CONCLUSIONS
The extent of potential benefits from the interventions was difficult to judge, due to study limitations. Future interventions should incorporate a clear theoretical framework and involve patients and clinicians in the development process.
IMPLICATIONS FOR CANCER SURVIVORS
Our findings show exercise interventions have beneficial effects on CIPN symptoms although higher quality research is warranted. Behavioural interventions that increase patient's CIPN knowledge, improve self-management capacity and enable timely access to symptom management led to reduced CIPN symptoms.
Identifiants
pubmed: 33710510
doi: 10.1007/s11764-021-00997-w
pii: 10.1007/s11764-021-00997-w
pmc: PMC9971149
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
254-277Subventions
Organisme : National Institute for Health Research
ID : DRF-2018-11-ST2-017
Informations de copyright
© 2021. The Author(s).
Références
Crit Rev Oncol Hematol. 2018 Jan;121:90-100
pubmed: 29198853
NPJ Digit Med. 2019 Sep 2;2:85
pubmed: 31508496
BMJ. 2017 Jul 20;358:j2998
pubmed: 28729459
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
J Clin Oncol. 2020 Oct 1;38(28):3325-3348
pubmed: 32663120
Cancer Nurs. 2020 May/Jun;43(3):E172-E185
pubmed: 32187026
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
BMJ Open. 2019 Aug 15;9(8):e029954
pubmed: 31420394
J Natl Cancer Inst. 2002 Apr 17;94(8):558-84
pubmed: 11959890
BMC Cancer. 2018 Dec 4;18(1):1203
pubmed: 30514351
Ann Oncol. 2014 Feb;25(2):493-9
pubmed: 24478323
Int J Rehabil Res. 2016 Dec;39(4):368-371
pubmed: 27749517
Int Q Community Health Educ. 2013;34(4):391-414
pubmed: 25228486
JAMA Neurol. 2016 Jul 1;73(7):860-6
pubmed: 27183099
Oncol Nurs Forum. 2004 Sep 17;31(5):E75-83
pubmed: 15378104
Emerg Med J. 2003 Mar;20(2):164-8
pubmed: 12642531
BMJ. 2015 Feb 10;350:g7714
pubmed: 25670179
BMC Cancer. 2019 May 2;19(1):414
pubmed: 31046719
Psychooncology. 2004 Dec;13(12):857-66
pubmed: 15386794
BMJ Qual Saf. 2020 Sep;29(9):711-716
pubmed: 31488570
Int J Behav Nutr Phys Act. 2014 Jul 06;11:85
pubmed: 24997476
Implement Sci. 2009 May 21;4:29
pubmed: 19460163
Ann Neurol. 2017 Jun;81(6):772-781
pubmed: 28486769
Neurorehabil Neural Repair. 2020 Mar;34(3):235-246
pubmed: 31976819
Exerc Sport Sci Rev. 2016 Apr;44(2):71-80
pubmed: 26829248
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Cancer Surviv. 2018 Apr;12(2):234-245
pubmed: 29159795
Eur J Cancer Care (Engl). 2019 May;28(3):e13011
pubmed: 30790382
J Am Geriatr Soc. 2008 Dec;56(12):2234-43
pubmed: 19093923
Cancer. 2008 Jun 1;112(11 Suppl):2593-606
pubmed: 18428192
CA Cancer J Clin. 2013 Nov-Dec;63(6):419-37
pubmed: 24590861
Comput Inform Nurs. 2016 Jul;34(7):322-9
pubmed: 27116414
Cancer Nurs. 2020 Jul/Aug;43(4):269-280
pubmed: 30888982
J Cancer Surviv. 2009 Sep;3(3):148-57
pubmed: 19626443
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
J Cancer Res Clin Oncol. 2018 Sep;144(9):1785-1792
pubmed: 29943097
Support Care Cancer. 2018 Apr;26(4):1019-1028
pubmed: 29243164
Am J Phys Med Rehabil. 2005 Apr;84(4):238-50
pubmed: 15785256
BMJ Qual Saf. 2016 Aug;25(8):626-32
pubmed: 26993640
J Pain. 2018 Apr;19(4):382-394
pubmed: 29229430
Behav Res Ther. 2021 Feb;137:103464
pubmed: 31780252
Pilot Feasibility Stud. 2019 Nov 08;5:127
pubmed: 31720005
J Cancer Surviv. 2020 Aug;14(4):444-463
pubmed: 32080785
Ann Behav Med. 2019 Jul 17;53(8):693-707
pubmed: 30304386
Cancer Manag Res. 2018 Oct 30;10:5125-5143
pubmed: 30464612
J Clin Oncol. 2008 Dec 20;26(36):5855-62
pubmed: 19029420
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Syst Rev. 2019 Dec 13;8(1):324
pubmed: 31836007
Support Care Cancer. 2019 Oct;27(10):3849-3857
pubmed: 30756229
J Clin Oncol. 2017 Aug 10;35(23):2604-2612
pubmed: 28586243
Implement Sci. 2012 Apr 24;7:38
pubmed: 22531013
Cancer. 2016 Jun 1;122(11):1782-91
pubmed: 27135464
Eur J Cancer Care (Engl). 2015;24(1):60-70
pubmed: 25053458
Ann Behav Med. 2008 Feb;35(1):116-22
pubmed: 18347912
JMIR Cancer. 2017 Jul 04;3(2):e8
pubmed: 28676465
PLoS Med. 2014 Aug 12;11(8):e1001690
pubmed: 25117057
J Clin Oncol. 2014 Jun 20;32(18):1941-67
pubmed: 24733808
Eur J Oncol Nurs. 2020 Feb;44:101676
pubmed: 31751847
Clin Breast Cancer. 2019 Dec;19(6):411-422
pubmed: 31601479
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Psychooncology. 2019 Mar;28(3):518-524
pubmed: 30597666
Trials. 2014 Jul 05;15:267
pubmed: 24996765
Am J Phys Med Rehabil. 2020 Apr;99(4):291-299
pubmed: 31592877
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 26786536
Med Sci Sports Exerc. 2008 Jun;40(6):1180-7
pubmed: 18460985
Physiother Res Int. 2011 Dec;16(4):237-44
pubmed: 21204162
Recent Results Cancer Res. 2011;186:1-10
pubmed: 21113758
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Worldviews Evid Based Nurs. 2004;1(3):176-84
pubmed: 17163895
J Neuroeng Rehabil. 2014 Dec 13;11:164
pubmed: 25496052
J Diabetes Res. 2020 Mar 6;2020:6978128
pubmed: 32215272
Comput Inform Nurs. 2017 Apr;35(4):201-211
pubmed: 28002115
Support Care Cancer. 2018 May;26(5):1607-1615
pubmed: 29204710
Psychooncology. 2018 Mar;27(3):713-724
pubmed: 29247584
Support Care Cancer. 2012 Nov;20(11):2639-47
pubmed: 22544223
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006953
pubmed: 19160308
Health Psychol Res. 2013 Sep 23;1(3):e28
pubmed: 26973913
Support Care Cancer. 2018 Feb;26(2):615-624
pubmed: 28963591
Patient Educ Couns. 2015 Mar;98(3):269-82
pubmed: 25483575
J Cancer Educ. 2018 Oct;33(5):1027-1035
pubmed: 28265863